Animal Gastroesophageal Reflux Disease Global Market Report 2026
상품코드:1938620
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
동물 위식도 역류증(GERD) 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 19억 8,000만 달러에서 2026년에는 21억 6,000만 달러로, CAGR 8.8%로 확대할 전망입니다. 지금까지의 성장 요인으로는 수의사들의 동물 GERD에 대한 낮은 인식, 반려동물의 높은 GERD 발병률, 동물병원의 고급 진단 기술 부족, 제네릭 의약품 의존도, 동물병원 및 진료소 증가 등을 꼽을 수 있습니다.
동물용 위식도 역류증 치료제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 29억 9,000만 달러에 달하며, CAGR은 8.5%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 내시경 검사 및 식도 내압 측정과 같은 첨단 진단 기술 개발, 영양 및 식이요법에 대한 관심 증가, 일반의약품 및 처방약 채택 증가, 수의학 E-Commerce 채널 확대, 개인 맞춤형 치료를 위한 AI 및 디지털 플랫폼 통합 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 GERD 진단을 위한 내시경 검사 및 pH 모니터링의 채택 증가, 관리에서 영양 보충제 및 식이요법의 사용 확대, 반려동물을 위한 처방약 및 일반의약품의 가용성 향상, GERD 치료를 위한 최소침습적 외과적 개입의 확대, 가축 및 반려동물을 위한 맞춤형 치료 프로토콜 등을 들 수 있습니다.
반려동물의 인간화가 진행됨에 따라 동물 위식도역류질환(GERD) 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물의 인간화란 주인이 반려동물을 인간 가족처럼 대하고, 인간과 같은 감정, 욕구, 행동을 투영하는 추세가 증가하고 있는 것을 말합니다. 이러한 추세는 주인과 반려동물 간의 정서적 유대감 강화에 의해 촉진되고 있으며, 인간의 기준에 부합하는 전문적인 헬스케어, 프리미엄 식품 및 웰빙 제품에 대한 수요가 증가하고 있습니다. 또한 반려동물의 인간화는 위식도역류질환(GERD)과 같은 건강 문제에 대한 인식을 높이고, 주의 깊은 보호자들이 수의사 진료를 받도록 유도하여 진단, 치료 및 예방책에 대한 수요를 증가시키고 있습니다. 예를 들어 미국 비영리 산업 단체인 미국 반려동물 제품 협회(APPA)에 따르면 2023-2024년 미국내 8,690만 가구(전체 가구의 66%)가 반려동물을 키우고 있으며, 이는 2022년 62%에서 증가한 수치입니다. 이처럼 반려동물의 인간화가 진행되면서 동물용 위식도역류질환(GERD) 시장을 촉진하고 있습니다.
동물 의료비 증가는 향후 동물 위식도역류질환 시장의 성장을 촉진할 것으로 예측됩니다. 동물 헬스케어는 동물의 평생에 걸친 건강 유지와 복지 향상을 목적으로 질병 예방, 건강 문제의 진단, 치료, 치료를 제공하는 케어 전반을 의미합니다. 반려동물 보호자들이 동물의 삶의 질과 수명을 향상시키기 위해 예방 의료와 고급 의료를 우선시하는 경향이 강해지면서 동물 건강관리 비용은 증가하는 추세입니다. 이에 따라 동물 의료 서비스, 진단, 치료의 이용이 확대되고 있습니다. 동물 위식도역류질환의 관리는 증상 조절과 합병증 예방을 위해 반복적인 수의사 진료, 진단 검사, 장기 투약, 식이 관리가 필요하므로 의료비 증가 요인으로 작용하고 있습니다. 예를 들어 미국 비영리단체인 미국 반려동물제품협회(APPA)에 따르면 2025년 3월 기준 2024년 반려동물 의료 및 제품 판매에 대한 총 지출액은 398억 달러에 달했습니다. 따라서 동물 의료비 증가가 동물 위식도역류질환 시장의 성장을 촉진하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Animal gastroesophageal reflux disease (GERD) occurs when stomach acid or bile flows back into the esophagus, leading to irritation and inflammation. This condition can cause symptoms such as vomiting, regurgitation, weight loss, and discomfort during eating. Diagnosing and treating GERD in animals aims to relieve discomfort, enhance quality of life, and prevent complications such as esophagitis, ulcers, or strictures.
The main product types for managing animal GERD include treatment and diagnostic options. Treatment involves products designed to manage and alleviate GERD symptoms in animals, such as antacids, proton pump inhibitors, and other medications that reduce stomach acid and support digestive health. These treatments are available in over-the-counter (OTC) and prescription forms, with administration routes including oral and injectable. GERD treatments are used for both companion animals and livestock. Distribution channels for these products include veterinary hospitals and clinics, retail pharmacies, and e-commerce platforms.
Tariffs have affected the animal gastroesophageal reflux disease market by increasing the cost of imported diagnostic devices, medications, and surgical instruments, impacting veterinary hospitals, clinics, and e-commerce channels, particularly in North America and Europe. Prescription medications and advanced diagnostic tools like endoscopy and pH monitoring are most affected. On the positive side, tariffs are encouraging local manufacturing and regional production of GERD-related products, potentially enhancing supply stability and reducing import dependency.
The animal gastroesophageal reflux disease market research report is one of a series of new reports from The Business Research Company that provides animal gastroesophageal reflux disease market statistics, including animal gastroesophageal reflux disease industry global market size, regional shares, competitors with a animal gastroesophageal reflux disease market share, detailed animal gastroesophageal reflux disease market segments, market trends and opportunities, and any further data you may need to thrive in the animal gastroesophageal reflux disease industry. This animal gastroesophageal reflux disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The animal gastroesophageal reflux disease market size has grown strongly in recent years. It will grow from $1.98 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limited awareness of animal gerd among veterinarians, high prevalence of gerd in companion animals, lack of advanced diagnostics in veterinary hospitals, reliance on generic medications, growth of veterinary clinics and hospitals.
The animal gastroesophageal reflux disease market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to development of advanced diagnostic techniques such as endoscopy and manometry, increasing focus on nutritional and dietary interventions, rising adoption of otc and prescription drugs, expansion of veterinary e-commerce channels, integration of ai and digital platforms for personalized treatment. Major trends in the forecast period include rising adoption of endoscopy and ph monitoring for gerd diagnosis, increasing use of nutritional supplements and dietary modifications in management, growth in prescription and otc medication availability for companion animals, expansion of minimally invasive surgical interventions for gerd treatment, customized treatment protocols for livestock and companion animals.
The increasing humanization of pets is expected to drive the growth of the animal gastroesophageal reflux disease market. Humanization of pets refers to the rising trend of pet owners treating their animals more like human family members, attributing human-like emotions, needs, and behaviors to them. This trend is fueled by the strengthening emotional bonds between owners and their pets, which boosts demand for specialized healthcare, premium diets, and wellness products that align with human standards. Humanization also raises awareness of health issues such as gastroesophageal reflux disease (GERD), prompting attentive owners to seek veterinary care and increasing demand for diagnostics, treatments, and preventive options. For example, in April 2024, according to the American Pet Products Association, a US-based not-for-profit industry association, 86.9 million US households had a pet in 2023-2024, representing 66% of households, up from 62% in 2022. Thus, the growing humanization of pets is propelling the animal gastroesophageal reflux disease market.
The rising expenditure on animal healthcare is expected to drive the growth of the animal gastroesophageal reflux disease market going forward. Animal healthcare encompasses the care and treatment provided to animals to prevent diseases, diagnose health problems, deliver medical treatment, and maintain overall health and well-being throughout their lives. Spending on animal healthcare is increasing as pet owners prioritize preventive and advanced medical care to enhance the quality and longevity of their animals' lives, leading to greater utilization of veterinary services, diagnostics, and treatments. Management of animal gastroesophageal reflux disease contributes to higher healthcare spending due to repeated veterinary consultations, diagnostic tests, long-term medication, and dietary management required to control symptoms and prevent complications. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit organization, total spending in 2024 on Veterinary Care & Product Sales amounted to $39.8 billion. Therefore, rising expenditure on animal healthcare is driving the growth of the animal gastroesophageal reflux disease market.
Leading players in the animal gastroesophageal reflux disease market are developing specialized diets that support gastrointestinal health to improve digestion and manage symptoms of gastroesophageal reflux disease in pets. Gastrointestinal support diets are specially formulated pet foods designed to alleviate and manage gastrointestinal disorders. These diets typically contain easily digestible ingredients, balanced nutrients, and added fibers or probiotics to promote digestive health and overall well-being. For example, in April 2024, Royal Canin, a USA-based subsidiary of Mars Incorporated and manufacturer of cat and dog food, expanded its veterinary gastrointestinal (GI) portfolio by introducing five new diets aimed at improving gastrointestinal health in pets. Developed in collaboration with researchers, veterinarians, and specialists, these diets target GI issues in both dogs and cats, including food-responsive sensitivities and fat-restricted diets. New options include gastrointestinal low-fat, hydrolyzed protein canine, and gastrointestinal hydrolyzed protein feline diets, all formulated with highly digestible ingredients to support long-term gastrointestinal health.
Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Sante Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc. , VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC
North America was the largest region in the animal gastroesophageal reflux disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the animal gastroesophageal reflux disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The animal gastroesophageal reflux disease market consists of revenues earned by entities by providing services such as specialized veterinary care, prescription medications, diagnostic testing and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The animal gastroesophageal reflux disease market also includes sales of gastrointestinal support diets, medications and hydrolyzed protein diets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Animal Gastroesophageal Reflux Disease Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses animal gastroesophageal reflux disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for animal gastroesophageal reflux disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal gastroesophageal reflux disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Treatment; Diagnostics
2) By Mode: Over-The-Counter (OTC); Prescription
3) By Route Of Administration: Oral; Injectable
4) By Animal: Companion Animals; Livestock Animal
5) By Distribution Channel: Veterinary Hospitals And Clinics; Retail Pharmacies; E-Commerce
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.1.5 Biotechnology, Genomics & Precision Medicine
4.2. Major Trends
4.2.1 Rising Adoption Of Endoscopy And Ph Monitoring For Gerd Diagnosis
4.2.2 Increasing Use Of Nutritional Supplements And Dietary Modifications In Management
4.2.3 Growth In Prescription And Otc Medication Availability For Companion Animals
4.2.4 Expansion Of Minimally Invasive Surgical Interventions For Gerd Treatment
4.2.5 Customized Treatment Protocols For Livestock And Companion Animals
5. Animal Gastroesophageal Reflux Disease Market Analysis Of End Use Industries
5.1 Veterinary Hospitals
5.2 Veterinary Clinics
5.3 Companion Animal Owners
5.4 Livestock Farms
5.5 Research Institutions
6. Animal Gastroesophageal Reflux Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Animal Gastroesophageal Reflux Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Animal Gastroesophageal Reflux Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Animal Gastroesophageal Reflux Disease Market Size, Comparisons And Growth Rate Analysis
7.3. Global Animal Gastroesophageal Reflux Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Animal Gastroesophageal Reflux Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Animal Gastroesophageal Reflux Disease Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Treatment, Diagnostics
9.2. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Over-The-Counter (OTC), Prescription
9.3. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Injectable
9.4. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Companion Animals, Livestock Animal
9.5. Global Animal Gastroesophageal Reflux Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce
9.6. Global Animal Gastroesophageal Reflux Disease Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Animal Gastroesophageal Reflux Disease Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Animal Gastroesophageal Reflux Disease Market
12.1. China Animal Gastroesophageal Reflux Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Animal Gastroesophageal Reflux Disease Market
13.1. India Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Animal Gastroesophageal Reflux Disease Market
14.1. Japan Animal Gastroesophageal Reflux Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Animal Gastroesophageal Reflux Disease Market
15.1. Australia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Animal Gastroesophageal Reflux Disease Market
16.1. Indonesia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Animal Gastroesophageal Reflux Disease Market
17.1. South Korea Animal Gastroesophageal Reflux Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Animal Gastroesophageal Reflux Disease Market
19.1. South East Asia Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Animal Gastroesophageal Reflux Disease Market
20.1. Western Europe Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Animal Gastroesophageal Reflux Disease Market
21.1. UK Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Animal Gastroesophageal Reflux Disease Market
23.1. France Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Animal Gastroesophageal Reflux Disease Market
26.1. Eastern Europe Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Animal Gastroesophageal Reflux Disease Market
27.1. Russia Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Animal Gastroesophageal Reflux Disease Market
28.1. North America Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Animal Gastroesophageal Reflux Disease Market
29.1. USA Animal Gastroesophageal Reflux Disease Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Animal Gastroesophageal Reflux Disease Market
31.1. South America Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Animal Gastroesophageal Reflux Disease Market
32.1. Brazil Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Animal Gastroesophageal Reflux Disease Market
33.1. Middle East Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Animal Gastroesophageal Reflux Disease Market
34.1. Africa Animal Gastroesophageal Reflux Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Animal Gastroesophageal Reflux Disease Market, Segmentation By Product, Segmentation By Mode, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Animal Gastroesophageal Reflux Disease Market Regulatory and Investment Landscape
36. Animal Gastroesophageal Reflux Disease Market Competitive Landscape And Company Profiles
